Every recall we track for Fresenius Kabi Compounding, LLC — 15 in all — plus the complaints and injury reports the public filed about them.
Fresenius Kabi recalls certain acyclovir sodium injections due to lack of sterility assurance. This may cause infections if used improperly. Contact the company for details.
Fresenius Kabi recalls specific vancomycin HCl injections due to lack of assurance of sterility. Affected lots may cause infections if used.
Fresenius Kabi recalls vancomycin HCl injection (1.5g) due to lack of sterility assurance. This may cause infections if used. Affected lots: C274-000049628, expiring May 2026.
Fresenius Kabi recalls specific ketamine HCl injections due to lack of sterility assurance. Affected lots may cause infections if used. Consumers should contact the manufacturer for details.
Fresenius Kabi recalls specific thiamine HCl injections due to lack of sterility assurance. Affected lots expire through May 2026; contact for return instructions.
Fresenius Kabi recalls thiamine injections due to cGMP violations. Affected lots from Canton, MA. No remedy stated in official notice.
Fresenius Kabi recalls phenylephrine injection due to cGMP violations. Affected units have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
Fresenius Kabi recalls a specific NORepinephrine injection product due to cGMP violations. This medication is for medical use only and should not be used without consulting a healthcare provider.
Fresenius Kabi recalls Oxytocin 0.9% Sodium Chloride Injection due to cGMP violations. Affected units have specific lot numbers and expiration dates. Contact for remedy details.
Fresenius Kabi recalls phenylephrine injections due to cGMP violations. Affected lots expire by October 2024. Consumers should contact the manufacturer for details.